心不全をマスターする

出版社： 文光堂
著者：
発行日： 2013-03-15
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784830681509
電子書籍版： 2013-03-15 （第1版第3刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,720 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,720 円(税込)

購入する

商品紹介

若手医師が求める日常診療のエッセンスをよりすぐり、かつ一歩進んだ知識を提供するムックシリーズ第10弾。近年の，拡張性心不全の概念をはじめとする心不全診療のパラダイムシフトをふまえ，2013年時点での最新の診断・治療を解説した一冊。相互に関連する事項には参照リンクを提示し，使いやすさと整合性を追求した。付録に「心不全の臨床研究一覧」を収載。心不全診療の「今」がオーバービューできる、若手医師の入門編として最適のガイド。

目次

  • 心不全をマスターする

    ―目次―

    ?．心不全を理解する
    　1. 心不全って何？
    　2. 心不全の実態（疫学）を知る
    　3. 収縮不全の進展機序を知る
    　4. 心不全では代償機構が働く
    　5. 拡張不全の機序を知る

    II．心不全を診断する

    III．心不全を治療する
    　１. 患者の自己管理と多職種による包括的管理が重要
    　２. 経口薬により治療する
    　３. 心不全における不整脈を管理する
    　　ミニレクチャー 収縮性心不全の新しい治療薬
    　４. 心不全におけるバイオマーカーと治療への応用
    　５. 心不全の背景疾患を管理、治療する
    　　A）心不全に合併する高血圧症
    　　B）冠動脈疾患?冠動脈疾患合併例の治療?
    　　C）糖尿病
    　　D）腎疾患
    　　E）慢性閉塞性肺疾患（COPD）
    　　F）睡眠呼吸障害
    　　G）甲状腺疾患
    　　H）貧血
    　　I）脚気（beriberi）
    　６. 心不全を合併する患者が手術を受けるときの管理
    　７. その他の非侵襲的治療
    　　A）運動療法・心臓リハビリテーション
    　　B）和温療法
    　　C）酸素療法
    　８. 心不全に対する外科治療を知る
    　９. 特殊な治療
    　　A）心臓再同期療法（CRT）と植込み型除細動器（ICD）
    　　B）補助人工心臓（VAD）
    　　C）心臓移植

    IV．急性心不全に対応する
    　１. 病態・診断
    　２. 内科的治療・デバイスを用いた治療
    　３. 外科的治療

    V．心不全末期の対応

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 心不全を理解する

P.11 掲載の参考文献
1) Tsuchihashi-Makaya M, et al. : Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction-a report from the Japanese cardiac registry of heart failure in cardiology (JCARECARD). Circ J 73 : 1893-1900, 2009.
PubMed
2) Fonarow GC, et al : for the OPTIMIZE-HF investigators and hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure, a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50 : 768-77, 2007.
PubMed
3) The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
 
4) van Heerebeek L, et al. : Diastolic stiffness of the failing diabetic heart ; importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 117 : 43-51, 2008.
PubMed
5) Aragno M, et al. : Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149 : 380-388, 2008.
PubMed
6) Shigeta T, et al. : Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation 126 : 1838-1851, 2012.
PubMed
7) Mann DL, Bristow MR : Mechanisms and models in heart failure ; the biomechanical model and beyond. Circulation 111 : 2837-2849, 2005.
PubMed
8) Konstam MA, et al. : Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction ; a meta-analytic approach. J. Am. Coll. Cardiol 56 : 392-406, 2010.
 
9) Borlaug BA, Redfield MM : Are systolic and diastolic heart failure overlapping or distinct phenotypes within the heart failure spectrum? Circulation 123 : 2006-2014, 2011.
PubMed
10) Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) : The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction ; an individual patient data meta-analysis. Eur Heart J first published online : August 6, 2011
 
11) Owan TE, et al. : Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 : 251-259, 2006.
PubMed
12) Shiba N, et al. : Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan- first report from the CHART-2 study. Circ J 75 : 823-833, 2011.
PubMed
13) Henkel DM, et al. : Death in heart failure ; a community perspective. Circ Heart Fail 1 : 91-97, 2008.
PubMed
14) Holland DJ, et al. : Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. J Am Coll Cardiol 57 : 1676-1686, 2011.
PubMed
15) Lund LH, et al. : Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 308 : 2108-2117, 2012.
PubMed
16) Solomon S, et al. : The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction ; a phase 2 double-blind randomised controlled trial. www.thelancet.com Published on line August 26, 2012 (http://dx.doi.org/10.1016/50140-6736(12)61227-6)
 
17) Thorneloe KS, et al. : An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 4 : 159ra148, 2012.
PubMed
P.23 掲載の参考文献
1) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン ; 慢性心不全治療ガイドライン (2010年改訂版) http://www.j-circ.or.jp/guideline/
 
2) Hunt SA, et al. : 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53 : e1-90, 2009.
 
3) Shiba N, Shimokawa H : Chronic heart failure in Japan ; implications of the CHART studies. Vasc Health Risk Manag 4 : 103-113, 2008.
PubMed
4) Shiba N, Shimokawa H : Prospective care of heart failure in Japan ; lessons form CHART studies. EPMA J 2 : 425-438, 2012.
 
5) Levy D, et al. : Long-term trends in the incidence of and survival with heart failure. New Engl J Med 347 : 1397-1402, 2002.
PubMed
6) Jhund PS, et al. : Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003. A population study of 5.1 million people. Circulation 119 : 515-523, 2009.
PubMed
7) Shiba N, et al. : Analysis of chronic heart failure Registry in the Tohoku district ; third year follow-up. Circ J 68 : 427-434, 2004.
PubMed
8) Shiba N, et al. : Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan-first report from the CHART-2 study-. Circ J 75 : 823-833, 2011.
PubMed
9) Tsutsui H, et al. : Characteristics and outcomes of patients with heart failure in general practices and hospitals ; Japanese Cardiac Registry of Heart Failure in General Practice (JCARE-GENERAL). Circ J 71 : 449-454, 2007.
PubMed
10) Hamaguchi S, et al. : Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73 : 1442-1447, 2009.
PubMed
11) 第75回日本循環器学会総会・学術集会. A large-scale hospital-based cohort of patients at high risk for heart failure : primary results of the CHART-2 study. 平成23年8月4日 パシフィコ横浜. Late Breaking Trial 3
 
12) Zile MR, et al. : Mode of death in patients with heart failure and a preserved ejection fraction. Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial. Circulation 121 : 1393-1405, 2010.
 
13) Ho KK, et al. : Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 : 107-115, 1993.
PubMed
14) Tsuchihashi M, et al. : Clinical characteristics and prognosis of hospitalized patients with congestive heart failure. A study in Fukuoka, Japan. Jpn Circ J 64 : 953-959, 2000.
PubMed
15) 柴信行 : 慢性心不全 : 診断と治療の進歩. I. 疫学と基礎研究の進歩 1. 疫学. 日本内科学会雑誌 101 (2) : 307-313, 2012.
 
16) Hamaguchi S, et al. : Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. A report from the Japanese Chardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 75 : 2403-2410, 2011.
PubMed
17) 柴信行, 下川宏明 : 心不全 Q&A. 慢性心不全の疫学データ. 救急・集中治療 22 : 7-13, 2010.
 
18) Ketchum ES, Levy WC : Establishing prognosis in heart failure : a multimarker approach. Prog Cardiovasc Dis 54 : 86-96, 2011.
PubMed
19) 柴信行, 下川宏明 : 脳・心・腎連関を絶つ降圧療法. MEDICINAL 2 : 44-53, 2012.
 
20) Shiba N, et al. : Prognostic importance of chronic kidney desease in Japanese patients with chronic heart failure. Implications of the CHART Study. Circ J 72 : 173-178, 2008.
 
21) Hamaguchi S, et al. : Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 73 : 1901-1908, 2009.
PubMed
22) Tada T, et al. : Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure. Int J Cardiol 128 : 419-421, 2008.
PubMed
23) Hamaguchi S, et al. : Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 74 : 2605-2611, 2010.
 
24) Nochioka K, et al. : Both high and low mody mass indexes are prognostic risks in Japanese patients with chronic heart failure. Implications form the CHART Study. J Cardiac Fail 16 : 880-887, 2010.
 
25) Bergamini C, et al. : Oxidative stress and hyperuricaemia ; pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 11 : 444-452, 2009.
PubMed
26) Hamaguchi S, et al. : Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiology 151 : 143-147, 2011.
 
27) Shiba N, et al. : Emerging problems of heart failure practice in Japanese women. Lessons from the CHART Study. Circ J 72 : 2009-2014, 2008.
PubMed
28) Hsich EM, Pina IL : Heart failure in women. A need for prospective data. J Am Coll Cardiol 54 : 491-498, 2009.
 
29) Arain FA, et al. : Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J 73 : 1774-1782, 2009.
PubMed
30) 柴信行, 下川宏明 : 拡張不全の疫学. わが国と海外では同じか. 医学のあゆみ 231 : 818-822, 2009.
Medical*Online
31) Bhatia RS, et al. : Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 : 260-269, 2006.
 
32) Owan TE, et al. : Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 : 251-259, 2006.
PubMed
33) Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) : The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction ; an individual patient data meta-analysis. Eur Heart J first published online : August 6, 2011.
 
34) Tsuchihashi-Makaya M, et al. : Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 73 : 1893-1900, 2009.
PubMed
35) Adams KF, et al. : Characteristics and outcomes of patients hospitalized for heart failure in the United States ; Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 : 209-216, 2005.
 
36) Nieminen MS, et al. : EuroHeart Failure Survey II (EHFS II) : a survey on hospitalized acute heart failure patients ; description of population. Eur Heart J 27 : 2725-2736, 2006.
 
P.35 掲載の参考文献
1) Zaugg M, et al. : Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102 : 344-350, 2000.
PubMed
2) Zhu WZ, et al. : Dual modulation of cell survival and cell death by beta (2) -adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98 : 1607-1612, 2001.
PubMed
3) Stefanelli C, et al. : Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim Biophys Acta 1450 : 406-413, 1999.
PubMed
4) Fujita T, Ishikawa Y : Apoptosis in heart failure. The role of beta-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyaocytes. Circ J 75 : 1811-1818, 2011.
PubMed
5) Sano M, et al. : p53-inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446 : 444-448, 2007.
PubMed
6) Marx SO, et al. : PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor) ; Defective regulation in failing hearts. Cell 101 : 365-376, 2000.
PubMed
7) Meyer M, et al. : Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92 : 778-784, 1995.
PubMed
8) Herron TJ, et al. : Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol 281 : H1217-H1222, 2001.
 
9) Tsutsui H, et al. : Oxidative stress and heart failure. Am J Phisiol 301 : H2181-H2190, 2011.
 
10) Takimoto E, Kass DA : Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49 : 241-248, 2007.
PubMed
11) Ritter O, et al. : Calcineurin in human heart hypertrophy. Circulation 105 : 2265-2269, 2002.
PubMed
12) Sussman MA, et al. : Dance band on the Titanic. Biomechanical Signaling in Cardiac Hypertrophy. Circ Res 91 : 888-898, 2002.
PubMed
13) Sugden PH, Clerk A : "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83 : 345-352, 1998.
PubMed
14) Woodiwiss AJ, et al. : Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103 : 155-160, 2001.
PubMed
15) Cerbai E, et al. : Characterization of the hyperpolarization-activated current, If, in ventricular myocytes from human failing heart. Circulation 95 : 568-571, 1997.
PubMed
16) Sato T, et al. : Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster. Am J Physiol 294 : H1164-H1173, 2008.
 
17) Dupont E, et al. : Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol 33 : 359-371, 2001.
PubMed
18) Matsumoto Y, et al. : Long-term endothelin A receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters. Circulation 106 : 613-619, 2002.
PubMed
19) Bers DM : Calcium and cardiac rhythms. Physiological and pathophysiological. Circ Res 90 : 14-17, 2002.
PubMed
20) Verkerk AO, et al. : Ionic mechanism of delayed afterdepolarizations in ventricular cells isolated from human endstage failing hearts. Circulation 104 : 2728-2733, 2001.
PubMed
21) Bers DM, et al. : Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes. Ann NY Acad Sci 1080 : 165-177, 2006.
 
P.43 掲載の参考文献
1) Katz AM : Cardiomyopathy of Overload-A Major Determinant of Prognosis in Congestive Heart Failure. N Engl J Med 322 : 100-110, 1990.
 
2) Nozawa T, et al. : Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of beta-receptors during development of hypertensive heart failure of rats. Circulation 97 : 2359-2367, 1998.
PubMed
3) Katz AM : Physiology of the Heart, 3rd ed. pp.255-286, Lippincott/Williams& Wilkins, Philadelphia, 2001.
 
4) Iwanaga Y, et al. : Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation 104 : 606-612, 2001.
PubMed
5) Takenaka H, et al. : Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension. J Mol Cell Cardiol 41 : 989-997, 2006.
PubMed
6) Morgan JP : Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 29 ; 325 (9) : 625-632, 1991.
 
P.49 掲載の参考文献
1) Melenovsky V, et al. : Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community, the role of atrial remodeling/dysfunction. J Am Coll Cardiol 49 : 198-207, 2007.
PubMed
2) Selby DE, et al. : Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 58 : 147-154, 2011.
PubMed
3) van Heerbeek L, et al. : Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113 : 1966-1973, 2006.
 
4) Yamamoto K, et al. : Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55 : 76-82, 2002.
 
5) Shigeta T, et al. : Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and-independent actions. Circulation 126 : 1838-1851, 2012.
PubMed

II. 心不全を診断する

P.71 掲載の参考文献
1) Sato N, et al. ; ATTEND Investigators : Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study ; rationale, design, and preliminary data. Am Heart J 159 (6) : 949-955.e1, 2010.
 
2) Tsutsui H, et al. ; Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J 71 : 449-454, 2007.
PubMed
3) Stevenson LW, Perloff JK : The limited reliability of physical sings for estimating hemodynamics in chronic heart failure. JAMA 261 (6) : 884-888, 1989.
 
4) Fukuta H, et al. : Contribution of right-sided heart enlargement to cardiomegaly on chest roentgenogram in diastolic and systolic heart failure. Am J Cardiol 99 : 62-67, 2007.
PubMed

III. 心不全を治療する

P.78 掲載の参考文献
1) McAlister FA, et al. : Multidisciplinary strategies for the management of heart failure patients at high risk for admission ; a systematic review of randomized trials. J Am Coll Cardiol 44 : 810-819, 2004.
PubMed
2) Dickstein K, et al. ; ESC Committee for Practice Guidelines (CPG) : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ; the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 : 2388-2442, 2008.
 
3) 日本循環器学会 : 慢性心不全治療ガイドライン (2010年改訂版). 日本循環器学会ホームページ.
 
4) Suskin N, et al. : Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 37 : 1677-1682, 2001.
PubMed
5) Frishman WH : Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev 15 : 257-263, 2007.
PubMed
6) Smart N, Marwick TH : Exercise training for patients with heart failure ; a systematic review of factors that improve mortality and morbidity. Am J Med 116 : 693-706, 2004.
PubMed
7) Hung IF, et al. : Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination ; a prospective cohort study. Clin Infect Dis 51 : 1007-1016, 2010.
PubMed
8) Phillips CO, et al. : Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure ; a meta-analysis. JAMA 291 : 1358-1367, 2004.
PubMed
P.97 掲載の参考文献
1) Dickstein K, et al. : ESC Committee for Practice Guidelines (CPG) : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
 
2) Fonarow GC, et al. : Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J 161 : 1024-1030, 2011.
PubMed
3) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン. 慢性心不全治療ガイドライン (2010年改訂版).
 
4) Masuyama T, et al. : Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J 76 : 833-842, 2012.
PubMed
5) The CONSENSUS Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 316 : 1429-1435, 1987.
 
6) The SOLVD investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congesteive heart failure. N Engl J Med 325 : 293-302, 1991.
PubMed
7) Packer M, et al. : Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100 : 2312-2318, 1999.
 
8) Pitt B, et al. : Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure ; randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet 355 : 1582-1587, 2000.
PubMed
9) Konstam MA, et al. : Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study) ; a randomised, double-blind trial. : Lancet 374 : 1840-1848, 2009.
PubMed
10) Granger CB, et al. : Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors ; the CHARM-Alternative trial. : Lancet 362 : 772-776, 2003.
PubMed
11) McMurray JJ, et al. : Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors ; the CHARM-Added trial. : Lancet 362 : 767-771, 2003.
PubMed
12) Matsumori A ; on behalf of the ARCH-J study investigators : Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J Heart Fail 5 : 669-677, 2003.
 
13) Cohn JN, Tognoni G ; Valsartan Heart Failure Trial Investigators : A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 : 1667-1675, 2001.
 
14) Pfeffer MA, et al. : Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 : 1893-1906, 2003.
 
15) Hori M, et al. : Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure ; the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 147 : 324-330, 2004.
PubMed
16) Packer M, et al. : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group. N Eng J Med 334 : 1349-1355, 1996.
 
17) Packer M, et al. for the COPERNICUS study group : Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 : 1651-1658, 2001.
 
18) The CIBIS II Investigators and Committees : The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) : a randomised trial. : Lancet 353 : 9-13, 1999.
 
19) The MERIT-HF Study Group : Effect of metoprolol CR/XL in chronic heart failure ; Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 : 2001-2007, 1999.
 
20) Dungen HD, et al. : Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure ; the CIBIS-ELD trial. : Eur Heart Fail 13 : 670-680, 2011.
PubMed
21) Metra M, et al. : Differential effects of beta-blockers in patients with heart failure ; A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102 : 546-551, 2000.
 
22) Poole-Wilson PA, et al. : Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET) ; randomised controlled trial. Lancet 362 : 7-13, 2003.
 
23) Beta-Blocker Evaluation of Survival Trial Investigators : A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 : 1659-1667, 2001.
 
24) Zhou Q, et al. : Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med 17 : 1003-1009, 2011.
PubMed
25) CIBIS Investigators and Committees : A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90 : 1765-1773, 1994.
PubMed
26) Bristow MR, et al. : Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94 : 2807-2816, 1996.
PubMed
27) Dargie HJ : Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction ; the CAPRICORN randomised trial. Lancet 357 : 1385-1390, 2001.
PubMed
28) Remme WJ, et al. : The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther. 18 : 57-66, 2004.
 
29) Willenheimer R, et al. : Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence ; results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112 : 2426-2435, 2005.
PubMed
30) Shiba N, et al. : Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study. Circ J 75 : 823-833, 2011.
PubMed
31) Shiba N, et al. : Analysis of chronic heart failure registry in the Tohoku district : third year follow-up. Circ J 68 : 427-434, 2004.
PubMed
32) Greenberg B, et al. : Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91 : 2573-2581, 1995.
 
33) Khattar RS, et al. : Regression of left ventricular remodeling in chronic heart failure : Comparative and combined effects of captopril and carvedilol. Am Heart J 142 : 704-713, 2001.
PubMed
34) Meredith PA, et al. : Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure ; Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol 52 : 2000-2007, 2008.
 
35) Pitt B, et al. : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Eng J Med 341 : 709-717, 1999.
 
36) Juurlink DN, et al. : Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 : 543-551, 2004.
PubMed
37) Pitt B, et al. : Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 : 1309-1321, 2003.
PubMed
38) Zannad F, et al. : Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364 : 11-21, 2011.
PubMed
39) McMurray JJ, et al. : Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart fail 1 : 17-24, 2008.
PubMed
40) Solomon SD, et al. : Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation 119 : 530-537, 2009.
 
41) Konstam MA, Jr et al. : Effects of oral tolvaptan in patients hospitalized for worsening heart failure ; the EVEREST Outcome Trial. : JAMA 297 : 1319-1331, 2007.
 
42) Matsuzaki M, et al. : Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics : a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovascular Drugs Ther 25 (Suppl 1) : S33-45, 2011.
 
43) Udelson JE, et al. : A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction. J Cardiac Fail 17 : 973-981, 2011.
PubMed
44) Cohn JN, et al. : Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314 : 1547-1552, 1986.
 
45) Cohn JN, et al. : A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 : 303-310, 1991.
PubMed
46) Taylor AL, et al. : Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 : 2049-2057, 2004.
PubMed
47) The Digitalis Investigation Group : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 : 525-533, 1997.
 
48) Uretsky BF, et al. : Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure ; results of the PROVED trial. : PROVED Investigative Group. J Am Coll Cardiol 22 : 955-962, 1993.
 
49) Butler J, et al. : Digoxin use and heart failure outcomes ; results from the Valsartan Heart Failure Trial (Val-HeFT). Congest Heart Fail 16 : 191-195, 2010.
PubMed
50) Rathore SS, et al. : Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 : 871-878, 2003.
PubMed
51) Ruelaz RA, Rahimtoola SH : Was it digoxin toxicity? -very likely. J Card Fail 11 (2) : 87-90, 2005.
PubMed
52) Menger L, et al. : Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 4 : 143ra99, 2012.
PubMed
53) Lubsen J, et al. : Effect of pimobendan on exercise capacity in patients with heart failure ; main results from the Pimobendan in Congestive Heart Failure (PICO) trial. : Heart 76 : 223-231, 1996.
PubMed
54) The EPOCH Study Group : Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure ; the effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 66 : 149-157, 2002.
 
55) Yoshikawa T, et al. : Effectiveness of carvedilol alone versus carvedilol+pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group. Am J Cardiol 85 : 1495-1497, 2000.
 
56) Tsuchihashi-Makaya M, et al. : Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 73 : 1893-1900, 2009.
PubMed
57) Hunt SA, et al. : ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation 112 : e154-235, 2005.
PubMed
58) Holland DJ, et al. : E Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol 57 : 1676-1686, 2011.
PubMed
59) Lund LH, et al. : Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 308 : 2108-2117, 2012.
PubMed
60) Solomon S, et al. : The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction ; a phase 2 double-blind randomised controlled trial. www.thelancet.com Published on line August 26, 2012_ http://dx.doi.org/10.1016/50140-6736(12)61227-6
 
P.108 掲載の参考文献
1) Camm AJ, Savelieva I : Atrial fibrillation ; Advances and perspectives. Dialog Cardiovasc Med 8 : 183-202, 2003.
 
2) de Vos CB, et al. : Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55 : 725-731, 2010.
PubMed
3) Packer DL, et al. : Tachycardia-induced cardiomyopathy ; A reversible form of left ventricular dysfunction. Am J Cardiol 57 : 563-570, 1986.
PubMed
4) Wyse DG, et al. : A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 : 1825-1833, 2002.
PubMed
5) Fauchier L, et al. : Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol 103 : 248-254, 2009.
PubMed
6) Van Gelder IC, et al. for the RACE II Investigator : Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362 : 1363-1373, 2010.
PubMed
7) Konishi M, et al. : Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J 74 : 1127-1134, 2010
PubMed
8) Hohnloser SH, et al. : Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy ; an ACTIVE W Substudy. J Am Coll Cardiol 50 : 2156-2161, 2007.
PubMed
9) Gage BF, et al. : Validation of clinical classification schemes for predicting stroke ; Results from the National Registry of Atrial Fibrillation. JAMA 285 : 2864-2870, 2001.
 
10) Olesen JB, et al. : Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation ; nationwide cohort study. BMJ 342 : d124, 2011.
PubMed
11) Yasaka M, et al. : Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40 : 1183-1188, 2001.
PubMed
12) Sato H, et al. : Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation ; Japan Atrial Fibrillation Stroke Trial. Stroke 37 : 447-451, 2006.
PubMed
13) Connolly SJ, et al. : Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361 : 1139-1151, 2009.
PubMed
14) Doval HC, et al. : Randomised trial of low-dose amiodarone in severe congestive heart failure ; Grupode Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344 : 493-498, 1994.
 
15) Singh SN, et al. : Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia ; Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 333 : 77-82, 1995.
PubMed
16) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) : A randomised trial. Lancet 353 : 9-13, 1999.
 
17) Packer M, et al. : Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 : 1651-1658, 2001.
PubMed
18) Zhou Q, et al. : Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med 17 : 1003-1009, 2011.
PubMed
19) Haissaguerre M, et al. : Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 359 : 677-678, 2002.
PubMed
P.110 掲載の参考文献
1) Swedberg K, et al. : Ivabradine and outcomes in chronic heart failure (SHIFT) ; a randomised placebo-controlled study. Lancet 376 : 875-885, 2010.
PubMed
2) Tardif JC, et al. ; on behalf of the SHIFT Investigators : Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function ; results from the SHIFT echocardiography substudy. Eur Heart J 32 : 2507-2515, 2011.
 
3) Bohm M, et al. : Heart rate as a risk factor in chronic heart failure (SHIFT) ; the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376 : 886-894, 2010.
 
4) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 33 : 1787-1847, 2012.
PubMed
5) Malik FI, et al. : Cardiac myosin activation ; a potential therapeutic approach for systolic heart failure. Science 331 : 1439-1443, 2011.
PubMed
6) Teerlink JR, et al. : Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil ; A first-in-man study. Lancet 378 : 667-675, 2011.
PubMed
7) Cleland JGF, et al. : The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure ; A double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378 : 676-683, 2011.
PubMed
P.117 掲載の参考文献
1) Biomark Defin Work Group : Clin Pharmacol Ther 69 : 89-95, 2001.
 
2) Cohn et al. : Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 : 819-823, 1984.
PubMed
3) NACB writing group members ; National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines : Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116 : e99-e109, 2007.
 
4) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 慢性心不全治療ガイドライン (2010年改訂版).
 
5) Maisel AS, et al. ; Breathing Not Properly Multinational Study Investigators : Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 : 161-167, 2002.
 
6) Januzzi JL Jr, et al. : The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 : 948-954, 2005.
 
7) Fonarow GC, et al. : Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 : 1943-1950, 2007.
PubMed
8) Pfisterer M, et al. : BNP-guided vs symptom-guided heart failure therapy ; the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301 : 383-392, 2009.
PubMed
9) Sato Y, et al. : Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 : 369-374, 2001.
PubMed
10) Sato Y et al. : Biochemical markers of myocyte injury in heart failure. Heart 90 : 1110-1113, 2004.
PubMed
11) Taniguchi R, et al. : Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 68 : 1160-1164, 2004.
 
12) Latini R, et al. : Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116 : 1242-1249, 2007.
PubMed
13) Sato Y, et al. : Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin. Int J Cardiol 126 : 171-176, 2008.
PubMed
14) Kuwabara Y, et al. : Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 71 : 1047-1051, 2007.
PubMed
15) Mizuno Y, et al. : Aldosterone production is activated in failing ventricle in humans. Circulation 103 : 72-77, 2001.
PubMed
16) Tsutamoto T, et al. : Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 36 : 838-844, 2000.
PubMed
17) Yamaji M, et al. : Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure ; the impact of oxidative stress. Circ Heart Fail 2 : 608-615, 2009.
PubMed
18) Braunwald E, et al. : Biomarkers in Heart Failure. N Engl J Med 358 : 2149-2159, 2008.
 
19) van Kimmenade RR, et al. : Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48 : 1217-1224, 2006.
PubMed
P.123 掲載の参考文献
1) Shiba N, et al. : Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study. Circ J 75 : 823-833, 2011.
PubMed
2) Tsuchihashi-Makaya M, et al. : Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARECARD). Circ J 73 : 1893-1900, 2009.
PubMed
3) Packer M, et al. : Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335 : 1107-1114, 1996.
 
4) ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group : Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic ; The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 : 2981-2997, 2002.
PubMed
5) Saito F, Kimura G : Antihypertensive mechanism of diuretics based on pressure-natriuresis relationship. Hypertension 27 : 914-918, 1996.
PubMed
6) Cohn JN, Tognoni G ; Valsartan Heart Failure Trial Investigators : A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 : 1667-1675, 2001.
 
7) McMurray JJ, et al. : Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors ; the CHARM-Added trial. Lancet 362 : 767-771, 2003.
PubMed
8) Yusuf S, et al. : Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 : 1547, 2008.
 
9) 日本高血圧学会 : 高血圧治療ガイドライン 2009.
 
10) Dickstein K, et al. ; ESC Committee for Practice Guidelines (CPG) : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
 
11) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 慢性心不全治療ガイドライン (2010年改訂版).
 
P.130 掲載の参考文献
1) Burch GE, et al. : Ischemic cardiomyopathy. Am Heart J 79 : 291-292, 1970.
PubMed
2) Richardson P, et al. : Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 : 841-842, 1996.
PubMed
3) Jessup M, Brozena S : Heart failure. N Engl J Med 348 : 2007-2018, 2003.
PubMed
4) Shiba N, et al. : Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction--comparison with nonischemic cardiomyopathy. Circ J 20 69 : 143-149, 2005.
 
5) Maron BJ, et al. : Contemporary definitions and classification of the cardiomyopathies ; an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee ; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups ; and Council on Epidemiology and Prevention. Circulation 113 : 1807-1816, 2006.
PubMed
6) O'Keefe JH Jr, et al. : Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure. J Nucl Cardiol 7 : 3-7, 2000.
PubMed
7) Wikstrom G, et al. : The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J 30 : 782-788, 2009.
PubMed
8) Rahimtoola SH : A perspective on three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72 (Suppl V) : 123-135, 1985.
 
9) Braunwald E, Kloner RA : The stunned myocardium ; prolonged, postischemic ventricular dysfunction. Circulation 66 : 1146-1149, 1982.
PubMed
10) Allman KC, et al. : Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction ; a meta-analysis. J Am Coll Cardiol 39 : 1151-1158, 2002.
PubMed
11) Elefteriades JA, et al. : Coronary artery bypass grafting in severe left ventricular dysfunction ; excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 22 : 1411-1417, 1993.
 
12) Serruys PW, et al. : Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 : 961-972, 2009.
PubMed
13) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 心筋梗塞二次予防に関するガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_ogawah_h.pdf
 
14) CAPRIE Steering Committee : A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 : 1329-1339, 1996.
 
15) Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators : Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 93 : 969-973, 2004.
PubMed
16) Blood Pressure Lowering Treatment Trialists Collaboration : Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 25 : 951-958, 2007.
PubMed
P.133 掲載の参考文献
1) UK Prospective Diabetes Study (UKPDS) Group : Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 : 837-853, 1998.
 
2) Action to Control Cardiovascular Risk in Diabetes Study Group, et al. : Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 : 2545-2559, 2008.
 
3) ADVANCE Collaborative Group, et al. : Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 : 2560-2572, 2008.
 
4) Duckworth W, et al. ; VADT Investigators : Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 : 129-139, 2009.
PubMed
5) Gaede P, et al. : Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 : 383-393, 2003.
PubMed
6) Nathan DM, et al. ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group : Intensive diabetes treatment and cardiovascular disease in patients with type 1 N Engl J Med 353 (25) : 2643-2653, 2005.
 
7) Holman RR, et al. : 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 : 1577-1589, 2008.
PubMed
8) Chrysant SG, Chrysant GS : Clinical Implications of Cardiovascular Preventing Pleiotropic Effects of Dipeptidyl Peptidase-4 Inhibitors. Am J Cardiol 109 : 1681-1685, 2012.
PubMed
9) Munaf M, et al. : A meta-analysis of the therapeutic effects of glucagon-like-peptide-1 agonist in heart failure. Int J Peptide 2012 ; article ID 249827, 7 pages.
 
P.139 掲載の参考文献
1) Sarnak MJ, et al. : Kidney disease as a risk factor for development of cardiovascular disease ; a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 : 2154-2169, 2003.
PubMed
2) McAlister FA, et al. : Renal insufficiency and heart failure ; prognostic and therapeutic implications from a prospective cohort study. Circulation 109 : 1004-1009, 2004.
PubMed
3) Silverberg DS, et al. : The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 4 : 681-686, 2002.
PubMed
4) Ahmed A, et al. : Chronic kidney disease associated mortality in diastolic versus systolic heart failure ; a propensity matched study. Am J Cardiol 99 : 393-398, 2007.
PubMed
5) 日本腎臓学会 : CKD診療ガイド 2009. 東京医学社, 2009 (日本腎臓学会ホームページ).
 
6) Ginsberg JM, et al. : Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309 : 1543-1546, 1983.
PubMed
7) 日本循環器学会 : 脳血管障害, 腎機能障害, 末梢血管障害を合併した心疾患の管理に関するガイドライン. Circulation Journal 72 (Suppl) : 2008.
 
8) 蔦谷知佳子ほか : 血液透析患者における予後予測因子としてのNT-proBNPの有用性-心電図所見からの検討. 日本透析医学会雑誌 43 : 633-640, 2010.
 
9) Felker GM, et al. : Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 : 797-805, 2011.
PubMed
10) Tanaka M, et al. : The Na+ -excreting efficacy of indapamide in combination with furosemide in massive edema. Clin Exp Nephrol 9 : 122-126, 2005.
PubMed
11) Yoshitake I, et al. : Low-dose atrial natriuretic peptide for chronic kidney disease in coronary surgery. Ann Thorac Cardiovasc Surg 17 : 363-368, 2011.
PubMed
12) Perdue PW, et al. : "Renal dose" dopamine in surgical patients : dogma or science? Ann Surg 227 : 470-473, 1998.
PubMed
13) Singh AK, et al. : Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 : 2085-2098, 2006.
PubMed
14) McMurray JJ, et al. : Design of the reduction of events with darbepoetin alfa in heart failure (RED-HF) ; a Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 11 : 795-801, 2009.
PubMed
15) 日本腎臓学会 : エビデンスに基づくCKD診療ガイドライン 2009. 東京医学社, 2009 (日本腎臓学会ホームページ).
 
P.144 掲載の参考文献
1) 日本呼吸器学会 : COPD診断と治療のためのガイドライン 第3版. 2009.
 
2) Dickstein K, et al. : ESC guideline for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
PubMed
3) 大西勝也ほか : 左室拡張機能障害を有する患者における潜在的閉塞性換気障害の合併頻度. Therapeutic Research 30 : 807-812, 2009.
Medical*Online
4) Barnes PJ, Celli BR : Systemic manifestations and comorbidities of COPD. Eur Respir J 33 : 1165-1185, 2009.
PubMed
5) Macchia A, et al. : The prognosric influence of chronic obstructive pulmonary disease in patients hospitalized for chronic heart failure. Eur J Heart Fail 9 : 942-948, 2007.
PubMed
6) Fabbri LM, et al. : From COPD to chronic systemic inflammatory syndrome? Lancet 370 : 797-799, 2007.
PubMed
7) Sevenoaks MJ, Stockley RA : Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respi Res 7 : 70, 2006.
 
8) Rutten FH, et al. : Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26 : 1887-1894, 2005.
PubMed
9) Le Jemtel TH, et al. : Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49 : 171-180, 2007.
PubMed
10) 日本循環器学会 : 急性心不全治療ガイドライン (2011年改訂版).
 
11) Calverley PM, et al. : Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 : 775-789, 2007.
PubMed
12) Celli B, et al. : Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180 : 948-955, 2009.
PubMed
13) Anthonisen NR, et al. : The effects of a smoking cessation intervention on 14.5-year mortality ; a randomized clinical trial. Ann Intern Med 142 : 233-239, 2005.
PubMed
14) Chen J, et al. : Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 37 : 1950-1956, 2001.
PubMed
P.153 掲載の参考文献
1) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 循環器領域における睡眠呼吸障害の診断・治療に関するガイドライン.
 
2) Oldenburg O, et al. : Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail 10 (6) : 581-586, 2008.
PubMed
3) 百村伸一 : 慢性心不全の非薬物療法 治す 睡眠呼吸障害をどのように治療するか. Heart View 16 (5) : 492-498, 2012.
 
4) Teschler H, et al. : Adaptive pressure support servo-ventilation ; a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164 (4) : 614-619, 2001.
PubMed
5) Marin JM, et al. : Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure ; an observational study. Lancet 365 (9464) : 1046-1053, 2005.
PubMed
6) Kaneko Y, et al. : Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (13) : 1233-1241, 2003.
PubMed
7) Wang H, et al. : Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49 (15) : 1625-1631, 2007.
PubMed
8) Kasai T, et al. : Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133 (3) : 690-696, 2008.
PubMed
9) Tamura A, et al. : Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131 (1) : 130-135, 2007.
PubMed
10) Sasayama S, et al. : Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 70 (1) : 1-7, 2006.
PubMed
11) Sin DD, et al. : Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102 (1) : 61-66, 2000.
PubMed
12) Arzt M, et al. : Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure ; a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 (25) : 3173-3180, 2007.
PubMed
13) Yoshihisa A, et al. : Impact of adaptive servoventilation on cardiovascular function and prognosis in heart failure patients with preserved left venrtricular ejection fraction and sleep-disordered breathing. Eur J Heart Fail 2012 Dec 18.
PubMed
14) Kasai T, et al. : Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 3 (1) : 140-148, 2010.
PubMed
15) Takama N, Kurabayashi M : Effectiveness of adaptive servo-ventilation for treating heart failure regardless of the severity of sleep-disordered breathing. Circ J 75 (5) : 1164-1169, 2011.
PubMed
16) Koyama T, et al. : Short-term prognosis of adaptive servo-ventilation therapy in patients with heart failure. Circ J 75 (3) : 710-712, 2011.
PubMed
17) Bitter T, et al. : Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J 36 (2) : 385-392, 2010.
PubMed
P.156 掲載の参考文献
1) Klein I, Danzi S : Thyroid disease and the heart. Circulation 116 : 1725-1735, 2007.
PubMed
2) 中澤博江ほか : 循環器と甲状腺疾患. 内科 107 : 64-149, 2011.
 
3) Shimizu T, et al. : Hyperthyroidism and the management of atrial fibrillation. Thyroid 12 : 489-493, 2002.
PubMed
4) 國井葉ほか : バセドー病に合併する心房細動の治療の進め方. Medical Practice 28 : 2025-2030, 2011.
 
5) 心房細動治療 (薬物) ガイドライン. Circulation J 72 (Suppl IV) : 1581-1583, 2008.
 
6) 中澤博江 : 見逃されている甲状腺疾患による循環器異常. Medical Practice 26 : 235-139, 2009.
 
P.159 掲載の参考文献
1) Al-Ahmad A, et al. : Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 : 955-962, 2001.
PubMed
2) Ezekowitz JA, et al. : Anemia is common in heart failure and is associated with poor outcomes ; insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 : 223-225, 2003.
PubMed
3) Felker GM, et al. : Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 : 959-966, 2004.
PubMed
4) Tang YD, Katz SD : Anemia in chronic heart failure ; prevalence, etiology, clinical correlates, and treatment options. Circulation 113 : 2454-2461, 2006.
PubMed
5) Anand IS : Anemia and chronic heart failure ; implications and treatment options. J Am Coll Cardiol 52 : 501-511, 2008.
PubMed
6) Groenveld HF, et al. : Anemia and mortality in heart failure patients ; a systematic review and meta-analysis. J Am Coll Cardiol 52 : 818-827, 2008.
PubMed
7) Nanas JN, et al. : Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48 : 2485-2489, 2006.
PubMed
8) 日本鉄バイオサイエンス学会 : 鉄剤の適正使用による貧血治療指針 第2版. 響文社, 2009.
 
9) Torre-Amione G, et al. : Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction ; a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 : 1201-1206, 1996.
PubMed
10) Androne AS, et al. : Hemodilution is common in patients with advanced heart failure. Circulation 107 : 226-229, 2003.
PubMed
11) 日本透析医学会 : 慢性腎臓病患者における腎性貧血治療のガイドライン 2008年版. 日本透析医学会雑誌 41 : 661-716, 2008.
 
12) Ghali JK, et al. : Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 117 : 526-535, 2008.
PubMed
13) Kotecha D, et al. : Erythropoietin as a treatment of anemia in heart failure ; systematic review of randomized trials. Am Heart J 161 : 822-831, 2011.
PubMed
14) Toblli JE, et al. : Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50 : 1657-1665, 2007.
PubMed
15) Okonko DO, et al. : Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF ; a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 : 103-112, 2008.
 
16) Anker SD, et al. : Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361 : 2436-2448, 2009.
PubMed
P.163 掲載の参考文献
1) Watson JT, et al. : Outbreak of beriberi among African troops in Mogadishu, Somalia. PLos ONE, 2011. (http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0028345)
 
2) 入村達郎ほか : ストライヤー 基礎生化学. pp.262-272, 東京化学同人, 2010.
 
3) Bakker, SJL et al. : Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilation in cardiovascular beriberi. Medical Hypothesis 45 : 265-267, 1995.
 
4) 若林章ほか : 呼吸と循環 25 (9) : 781-790, 1977.
 
5) 山下政三 : 脚気の歴史. pp.1-7, 思文閣出版. 1995.
 
P.171 掲載の参考文献
1) Lee TH, et al. : Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery. Circulation 100 : 1043-1049, 1999.
PubMed
2) Fleisher LA, et al. ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ; American Society of Echocardiography ; American Society of Nuclear Cardiology ; Heart Rhythm Society ; Society of Cardiovascular Anesthesiologists ; Society for Cardiovascular Angiography and Interventions ; Society for Vascular Medicine ; Society for Vascular Surgery : 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 54 : e13-e118, 2009.
 
3) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2007年度合同研究班報告). 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2008年改訂版).
 
4) Poldermans D, et al. ; European Society of Cardiology : Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30 : 2769-2812, 2009.
 
5) Rohde LE, et al. : Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 87 : 505-509, 2001.
PubMed
6) Auerbach A, Goldman L : Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 113 : 1361-1376, 2006.
PubMed
7) McFalls E, et al. : Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 : 2795-2804, 2004.
PubMed
8) Poldermans D, et al. : A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery ; the DECREASE-V Pilot Study. J Am Coll Cardiol 49 : 1763-1769, 2007.
PubMed
9) Devereaux PJ, et al. ; POISE Study Group : Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) ; a randomised controlled trial. Lancet 371 : 1839-1847, 2008.
 
P.184 掲載の参考文献
1) Clark AL, et al. : Exercise limitation in chronic heart failure ; central role of the periphery. J Am Coll Cardiol 28 (5) : 1092-1102, 1996.
PubMed
2) Forissier JF, et al. : Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure. Eur J Heart Fail 3 (3) : 335-342, 2001.
PubMed
3) Belardinelli R, et al. : Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 97 (6) : 553-561, 1998.
PubMed
4) Antman EM, et al. : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction ; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ; developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians ; 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117 (2) : 296-329, 2008.
 
5) Pina IL, et al. : Exercise and heart failure ; A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107 (8) : 1210-1225, 2003.
PubMed
6) McKelvie RS, et al. : Effects of exercise training in patients with congestive heart failure ; a critical review. J Am Coll Cardiol 25 (3) : 789-796, 1995.
PubMed
7) Wenger NK, et al. : Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. Clin Pract Guidel Quick Ref Guide Clin 17 : 1-23, 1995.
PubMed
8) Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology : Recommendations for exercise training in chronic heart failure patients. Eur Heart J 22 (2) : 125-135, 2001.
 
9) Demopoulos L, et al. : Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. Circulation 95 (7) : 1764-1767, 1997.
 
10) Smart N, et al. : Exercise training in systolic and diastolic dysfunction ; effects on cardiac function, functional capacity, and quality of life. Am Heart J 153 (4) : 530-536, 2007.
PubMed
11) Adamopoulos S, et al. : Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 21 (5) : 1101-1106, 1993.
PubMed
12) Hambrecht R, et al. : Physical training in patients with stable chronic heart failure ; effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 25 (6) : p. 1239-1249, 1995.
PubMed
13) Katz SD, et al. : Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 99 (16) : 2113-2117, 1999.
 
14) Hambrecht R, et al. : Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 (24) : 2709-2715, 1998.
PubMed
15) Wang J, et al. : Physical training alters the pathogenesis of pacing-induced heart failure through endothelium-mediated mechanisms in awake dogs. Circulation 96 (8) : 2683-2692, 1997.
PubMed
16) La Rovere MT, et al. : Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 (9101) : 478-484, 1998.
PubMed
17) Roveda F, et al. : The effects of exercise training on sympathetic neural activation in advanced heart failure ; a randomized controlled trial. J Am Coll Cardiol 42 (5) : 854-860, 2003.
PubMed
18) La Rovere MT, et al. : Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106 (8) : 945-949, 2002.
PubMed
19) Adamopoulos S, et al. : Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 39 (4) : 653-663, 2002.
PubMed
20) Haykowsky MJ, et al. : A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients ; the benefit depends on the type of training performed. J Am Coll Cardiol 49 (24) : 2329-2336, 2007.
 
21) Belardinelli R, et al. : Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation 91 (11) : 2775-2784, 1995.
PubMed
22) Sullivan MJ, et al. : Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 78 (3) : 506-515, 1988.
PubMed
23) Giannuzzi P, et al. : Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure ; results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 108 (5) : 554-559, 2003.
PubMed
24) Passino C, et al. : Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47 (9) : 1835-1839, 2006.
PubMed
25) Kubo N, et al. : Exercise at ventilatory threshold aggravates left ventricular remodeling in patients with extensive anterior acute myocardial infarction. Am Heart J 147 (1) : 113-120, 2004.
PubMed
26) Shuichi T, et al. : Predictors of left ventricular remodeling in patients with acute myocardial infarction participating in cardiac rehabilitation. Circ J 68 (3) : 214-219, 2004.
PubMed
27) Belardinelli R, et al. : Randomized, controlled trial of long-term moderate exercise training in chronic heart failure ; effects on functional capacity, quality of life, and clinical outcome. Circulation 99 (9) : 1173-1182, 1999.
PubMed
28) Koukouvou G, et al. : Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure. J Rehabil Med 36 (1) : 36-41, 2004.
PubMed
29) Fitchet A, et al. : Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients ; a randomised controlled trial. Heart 89 (2) : 155-160, 2003.
PubMed
30) Piepoli MF, et al. : Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328 (7433) : 189, 2004.
PubMed
31) Smart N, Marwick TH : Exercise training for patients with heart failure ; a systematic review of factors that improve mortality and morbidity. Am J Med 116 (10) : 693-706, 2004.
PubMed
32) O'Connor CM, et al. : Efficacy and safety of exercise training in patients with chronic heart failure ; HF-ACTION randomized controlled trial. JAMA 301 (14) : 1439-1450, 2009.
PubMed
33) Hunt SA, et al. : 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults ; a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ; developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14) : e391-479, 2009.
 
34) Keteyian SJ, et al. : Differential effects of exercise training in men and women with chronic heart failure. Am Heart J 145 (5) : 912-918, 2003.
PubMed
35) Tyni-Lenne R, et al. : Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure. J Card Fail 4 (1) : 9-17, 1998.
PubMed
36) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2006年度合同研究班報告). 心血管疾患におけるリハビリテーションに関するガイドライン (2007年改訂版).
 
37) Rich MW, et al. : A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 (18) : 1190-1195, 1995.
PubMed
38) Grady KL, et al. : Team management of patients with heart failure ; A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation 102 (19) : 2443-2456, 2000.
 
39) McAlister FA, et al. : Multidisciplinary strategies for the management of heart failure patients at high risk for admission ; a systematic review of randomized trials. J Am Coll Cardiol 44 (4) : 810-819, 2004.
PubMed
40) 後藤葉一 : 慢性心不全マネジメントの将来像. 治療 89 : 1986-1996, 2007.
Medical*Online
P.189 掲載の参考文献
1) Tei C : Waon therapy ; Soothing warmth therapy. J Cardiol 49 : 301-304, 2007.
PubMed
2) Tei C, et al. : Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation 91 : 2582-2590, 1995.
PubMed
3) Tei C, Tanaka N : Thermal vasodilation as a treatment of congestive heart failure ; a novel approach. J Cardiol 27 : 29-30, 1996.
PubMed
4) Miyata M, et al. : Beneficial effects of Waon therapy on patients with chronic heart failure ; Results of a prospective multicenter study. J Cardiol 52 : 79-85, 2008,
 
5) Kihara T, et al. : Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol 53 : 214-218, 2009.
PubMed
6) Kihara T, et al. : Repeated sauna treatment improves vascular endothelial and cardiac function in Patients with chronic heart failure. J Am Coll Cardiol 39 : 754-759, 2002.
PubMed
7) Kihara T, et al. : Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 68 : 1146-1151, 2004.
PubMed
P.193 掲載の参考文献
1) 日本呼吸器学会肺生理専門委員会, 日本呼吸管理学会酸素療法ガイドライン作成委員会編 : 酸素療法ガイドライン. p.2, メディカルレビュー社, 2006.
 
2) 日本循環器学会 : 循環器病の診断と治療に関わるガイドライン (2010年度合同研究班報告). 急性心不全治療ガイドライン (2011年改訂版). p.25, 2011.
 
3) Levy P, et al. : Prevalence and impact of central sleep apnea in heart failure. Sleep Med Clin 2 : 615-621, 2007.
 
4) Backer WD, Javaheri S : Treatment of Sleep apnea in heart failure. Sleep Med Clin 2 : 631-638, 2007.
 
5) Aurora RN, et al. : The treatment of central sleep apnea syndrome in adults ; practice parameters with an evidencebased literature review and meta-analyses. Sleep 35 : 17-40, 2012.
PubMed
P.209 掲載の参考文献
1) Bonow RW, et al ; ACC/AHA2006 guidelines for the management of patients with valvular heart disease : A report of the American College of Cardiology/American Heart Association task force on practice guideline (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 48 : e1-e148, 2006.
 
2) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2006年度合同研究班報告). 弁膜疾患の非薬物治療に関するガイドライン (2007年改訂版).
 
3) Sakata R, et al. : Thoracic and cardiovascular surgery in Japan during 2008, Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 58 : 356-383, 2010.
PubMed
4) Ross J Jr, Braunwald E : Aortic stenosis. Circulation 38 (Suppl V) : V61-67 ; 1968.
 
5) Pepper J, Yacoub M : Valve-conserving operation for aortic regargitation. J Card Surg 12 : 15-16, 1997. Thoracic Surgery 1 : 57-67, 1996.
 
6) David TE, et al. : Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg 132 : 347-354, 2006.
PubMed
7) Freed LA, et al. : Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341 : 1-7, 1999.
PubMed
8) Hammermeister KE, et al. : Prediction of late survival in patients with mital valve disease from clinical, hemodynamic, and quantitative angiographic variables. Circulation 57 : 341-349, 1978.
 
9) Olson LJ, et al. : Surgical pathology of the mitral valve ; a study of 712 cases spanning 21 years. Mayo Clin Proc 62 : 22-34, 1987.
PubMed
10) Selzer A, Cohn KE : Natural history of mitral stenosis ; a review. Circulation 45 : 878-890, 1972.
PubMed
11) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2005年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2006年改訂版).
 
12) Nakano S, et al. : Reconsiderations of indications for open mitral commissurotomy based on pathologic features of the stenosed mitral valve. A fourteenyear follow-up study in 347 consecutive patients. J Thorac Cardiovasc Surg 94 : 336-342, 1987.
PubMed
13) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 慢性心不全治療ガイドライン (2010年改訂版).
 
14) Heimbecker Smith D, et al. : Surgical Technique for the Management of Constrictive Epicarditis Complicating Constrictive Pericarditis (The Waffle Procedure). Ann Thorac Surg 36 : 605-606, 1983.
PubMed
15) Faggian G, et al. : Constrictive Epicarditis After Open Heart Surgery ; The Turtle Cage Operation. J Cardiac Surg 5 : 318-320, 1990.
PubMed
16) Ha JW, et al. : Impact of left ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive pericarditis. J Thorac Cardiovasc Surg 136 : 1136-1141, 2008.
PubMed
17) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 慢性心不全治療ガイドライン (2010年改訂版).
 
18) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2004-2005年度合同研究班報告). 虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン. Circ J 70 (Suppl IV) : 1477-1553, 2006.
 
19) Velazquez EJ, et al. : Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med 364 : 1607-1616, 2011.
PubMed
20) Elefteriades JA, et al. : Coronary artery bypass grafting in severe left ventricular dysfunction ; excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 22 : 1411-1417, 1993.
 
21) Dor V, et al. : Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction ; comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 116 : 50-59, 1998.
PubMed
22) Suma H, et al. : Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann Thorac Surg 82 : 1344-1348, 2006.
PubMed
23) Matsui Y, et al. : Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg 124 : 395-397, 2002.
PubMed
24) Jones RH, et al. : Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360 : 1705-1717, 2009.
 
25) Buckberg GD : Questions and answers about the STICH trial ; a different perspective. J Thorac Cardiovasc Surg 130 : 245-249, 2005.
 
26) Batista RJ, et al. : Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card surg 11 : 96-97, 1996.
PubMed
27) Buckberg GD : Questions and answers about the STICH trial ; a different perspective. J Thorac Cardiovasc Surg 130 : 245-249, 2005.
 
28) The National Heart, Lung and Blood Institute Ballon Valvuloplasty Registry Participants : Multicenter experience with ballonmitral commissurotomy ; NHLBI balloon valvuloplasty registry report on immediate and 30-day followup results. Circulation 85 : 448-461, 1992.
 
29) Feldman T, et al. : Percutaneous Repair or Surgery for Mitral Regurgitation. N Engl J Med 364 : 1395-406, 2011.
 
30) Cribier A, et al. : Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis ; first human case description. Circulation 106 : 3006-3008, 2002.
PubMed
31) Smith CR, et al. : Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 : 2187-2198, 2011.
PubMed
P.221 掲載の参考文献
1) MERIT-HF Study Group : Effect of Metoprolol CR/XL in chronic heart failure ; Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353 : 2001-2007, 1999.
 
2) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2011年改訂版).
 
3) Linde C, et al ; REVERSE Study Group : Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52 (23) : 1834-1843, 2008.
 
4) Moss AJ, et al ; MADIT-CRT Trial Investigators : Cardiac-resynchronization therapy for the prevention of heartfailure events. N Engl J Med 361 (14) : 1329-1338, 2009.
PubMed
5) Yu CM, et al. : Benefits of Cardiac Resynchronization Therapy for Heart Failure Patients With Narrow QRS Complexes and Coexisting Systolic Asynchrony by Echocardiography. J Am Coll Cardiol 48 : 2251-2257, 2006.
PubMed
6) Chung ES, et al. : Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation 117 ; 2608-2616, 2008.
PubMed
7) Abraham WT, et al. ; MIRACLE Study Group : Cardiac resynchronization in chronic heart failure. N Engl J Med 346 : 1845-1853, 2002.
 
8) Cleland JGE, et al. ; the CARE-HF study investigators : The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med 352 : 2005.
 
9) Bristow MR, et al. ; the COMPANION Investigators : Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 : 2140-2150, 2004.
 
10) The AVID Investigators : A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 : 1576-1583, 1997.
 
11) Moss AJ, et al. : Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 : 1933-1940, 1996.
PubMed
12) Buxton AE, et al. ; the MUSTT investigators : A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 : 1882-1890, 1999.
 
13) Moss AJ, et al. ; the MADIT-II investigators : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 : 877-883, 2002.
 
14) Bardy GH, et al. ; the SCD-Heft investigators : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 
P.228 掲載の参考文献
1) Kirklin JK, et al. : INTERMACS Database for Durable Devices for Circulatory Support ; First Annual Report. J Heart Lung Transplant. 27 : 1065-1072, 2008.
PubMed
2) John R, et al. : Outcomes of a multicenter trial of the Levitronix C entriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 141 : 932-939, 2011.
 
3) Fabienne D, et al. : To "pump up" quality of life and exercise performance studies in patients with left ventricular assist devices. J Heart Lung Transplant 30 : 141-143, 2011.
PubMed
4) 絹川弘一郎 : いつステージ D 心不全に補助人工心臓 (VAD) を植え込むべきか? 医学のあゆみ 239 : 205-208, 2011.
Medical*Online
5) Alba AC, et al. : Usefulness of INTERMACS Scale to predict outcome after mechanical assist device implantation. J Heart Lung Transplant 28 : 827-833, 2009.
PubMed
P.234 掲載の参考文献
1) Barnard CN : A human cardiac transplant ; an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41 : 1271-1274, 1967.
 
2) Grattan MT, et al. : Eight-year results of cyclosporine-treated patients with cardiac transplants. J Thorac Cardiovasc Surg 99 : 500-509, 1990.
PubMed
3) Stehlik J, et al. : The registry of the international society for heart and lung transplantation ; twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 29 : 1089-1103, 2010.
PubMed
4) Fukushima N, et al. : Early result of heart transplantation in Japan ; Osaka University experience. Asian Cardiovasc Thorac Ann 12 : 154-158, 2004.
PubMed
5) 日本循環器学会心臓移植委員会ホームページ (http://plaza.umin.ac.jp)
 
6) Taylor DO, et al. : Registry of the International Society for Heart and Lung Transplantation ; Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 28 : 1007-1022, 2009.
PubMed
7) 日本臓器移植ネットワークホームページ (http://www.jotnw.or.jp)
 

IV. 急性心不全に対応する

P.244 掲載の参考文献
1) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 急性心不全ガイドライン (2011年改訂版).
 
2) Weintraub NL, et al. : Acute Heart Failure Syndromes ; Emergency Department Presentation, Treatment, and Disposition ; Current Approaches and Future Aims. A Scientific Statement From the American Heart Association. Circulation 122 : 1975-1996, 2010.
PubMed
3) Dickstein K, et al. : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
PubMed
4) Nohria A, et al. : Medical Management of Advanced Heart Failure. JAMA 287 : 628-640, 2002.
PubMed
5) Forrester JS, et al. : Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med 295 : 1404-1413, 1976.
PubMed
P.253 掲載の参考文献
1) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 急性心不全ガイドライン (2011年改訂版).
 
2) Weintraub NL, et al. : Acute Heart Failure Syndromes ; Emergency Department Presentation, Treatment, and Disposition ; Current Approaches and Future Aims. A Scientific Statement From the American Heart Association. Circulation 122 : 1975-1996. 2010.
PubMed
3) Dickstein K, et al. : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 29 : 2388-2442, 2008.
PubMed
4) Cuffe MS, et al. : Short-term intravenous milrinone for acute exacerbation of chronic heart failure ; a randomized controlled trial. JAMA 287 : 1541-1547, 2002.
PubMed
5) 日本循環器学会 : 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2009年改訂版). 日本循環器学会ホームページ.
 
P.265 掲載の参考文献
1) Little WC, Freeman GL : Pericardial disease. Circulation 113 : 1622-1632, 2006.
PubMed
2) Maisch B, et al. ; for the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology : Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 25 : 587-610, 2004.
 
3) Imazio M, et al. : Controversial issues in the management of pericardial diseases. Circulation. 121 : 916-928, 2010.
PubMed
4) Mokadam NA, et al. : Management of acute regurgitation in left-sided cardiac valves. Tex Heart Inst J 38 : 9-19, 2011.
PubMed
5) 日本循環器学会 : 循環器病の診断と治療に関するガイトライン (2007年度合同研究班報告). 感染性心内膜炎の予防と治療に関するガイトライン (2008年改訂版).
 
6) Evans CF, Gammie JS : Surgical management of mitral valve infective endocarditis. Semin Thorac Cardiovasc Surg 23 : 232-240, 2010.
 
7) Gelsomino S, et al. : Emergency Surgery for Native Mitral Valve Endocarditis ; The Impact of Septic and Cardiogenic Shock. Ann Thorac Surg 2012 Feb 16. [Epub ahead of print]
 
8) 日本循環器学会 : 急性心筋梗塞 (ST上昇型) の診療に関するガイドライン (2006-2007年度合同研究班報告). Circulation Journal 72 (Suppl IV) : 1347-1442, 2008.
 
9) Hochman JS, et al. : Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome ; a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am CollCardiol 36 (3 Suppl A) : 1063-1070, 2000.
 
10) Committee for Scientific Affairs ; Sakata R, et al. : Thoracic and cardiovascular surgery in Japan during 2008. Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 58 : 356-383, 2010.
 
11) Zoffoli G, et al. : A novel approach to ventricular rupture ; clinical needs and surgical technique. Ann Thorac Surg 93 : 1002-1003, 2012.
PubMed
12) Nishizaki K, et al. : Sutureless patch repair for small blowout rupture of the left ventricle after myocardial infarction. Jpn J Thorac Cardiovasc Surg 52 (5) : 268-271, 2004.
PubMed
13) Muto A, et al. : Sutureless repair with TachoComb sheets for oozing type postinfarction cardiac rupture. Ann Thorac Surg 79 : 2143-2145, 2005.
PubMed
14) Jouan J, et al. : Ischemic mitral valve prolapse ; mechanisms and implications for valve repair. Eur J Cardiothorac Surg 26 : 1112-1117, 2004.
PubMed
15) Thompson CR, et al. : Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction ; a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am CollCardiol 36 (3 Suppl A) : 1104-1109, 2000.
 
16) Daggett WM, et al. : Resection of acute ventricular aneurysm and ruptured interventricular septum after myocardial infarction. N Engl J Med 283 : 1507, 1970.
PubMed
17) Tirone E, et al. : Postinfarction ventricular septal rupture ; Repair by endocardial patch with infarct exclusion. J Thorac Cardiovasc Surg 110 : 1315-1322, 1995.
 
18) Caimmi PP, et al. : Double patch repair through a single ventriculotomy for ischemic ventricular septal defects. Ann Thorac Surg 89 : 1679-1681, 2010.
PubMed
19) Maltais S, et al. : Postinfarction ventricular septal defects ; towards a new treatment algorithm? Ann Thorac Surg 87 : 687-692, 2009.
PubMed
20) Thiele H, et al. : Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 30 : 81-88, 2009.
PubMed
21) Attia R, Blauth C : Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery? Interact Cardiovasc Thorac Surg 11 : 626-629, 2010.
PubMed

V. 心不全末期の対応

P.279 掲載の参考文献
1) Hunt SA, et al. ; American College of Cardiology ; American Heart Association Task Force on Practice Guidlines ; American College of Chest Physicians ; International Society for Heart and Lung Transplantation ; Heart Rhythm Society : ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) ; developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation ; endorsed by the Heart Rhythm Society. Circulation 112 (12) : e154-235, 2005.
 
2) Hunt SA, et al. : 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults ; a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ; developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14) : e391-479, 2009.
 
3) Dickstein K, et al. : ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ; the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10 (10) : 933-989, 2008.
 
4) Jaarsma T, et al. : Palliative care in heart failure ; a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11 (5) : 433-443, 2009.
 
5) Martinez-Selles M, et al. : End-stage heart disease in the elderly. Rev Esp Cardiol 62 (4) : 409-421, 2009.
PubMed
6) Goodlin SJ : Palliative Care in Congestive Heart Failure. J Am Coll Cardiol 54 (5) : 386-396, 2009.
PubMed
7) Gibbs JS, et al. : Living with and dying from heart failure ; the role of palliative care. Heart 88 (Suppl 2) : ii36-39, 2002.
 
8) Adler ED, et al. : Palliative care in the treatment of advanced heart failure. Circulation 120 (25) : 2597-2606, 2009.
PubMed
9) Friedrich EB, Bohm M : Management of end stage heart failure. Heart 93 (5) : 626-631, 2007.
PubMed
10) Pantilat SZ, Steimle AE : Palliative care for patients with heart failure. JAMA 291 (20) : 2476-2482, 2004.
PubMed
11) Allen LA, et al. : Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA 299 (21) : 2533-2542, 2008.
PubMed
12) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 274 (20) : 1591-1598, 1995.
 

付録 : 心不全に対する臨床トライアル

P.284 掲載の参考文献
1) The CONSENSUS Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 : 1429-1435, 1987.
 
2) The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 : 293-302, 1991.
PubMed
3) Cohn JN, et al. : A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 : 303-310, 1993.
 
4) The SOLVD Investigators : Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced Left ventricular ejection fractions. N Engl J Med 327 : 685-691, 1992.
PubMed
5) Pfeffer MA, et al. : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction-results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 : 669-677, 1992.
 
6) The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators : Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342 : 821-828, 1993.
 
7) Kober L, et al. : A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 : 1670-1676, 1995.
 
8) Packer M, et al. : Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100 : 2312-2318, 1999.
 
9) Pitt B, et al. : Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure ; randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet 355 : 1582-1587, 2000.
PubMed
10) Remme WJ, et al. : The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 18 : 57-66, 2004.
 
11) CIBIS Investigators and Committees : A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90 : 1765-1773, 1994.
PubMed
12) Packer M, et al. ; the U.S. carvedilol heart failure study group : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 : 1349-1355, 1996.
 
13) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) ; a randomised trial. Lancet 353 : 9-13, 1999.
 
14) Effect of metoprolol CR/XL in chronic heart failure ; Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet : 353 : 2001-2007, 1999.
PubMed
15) The RESOLVD Investigators : Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy ; the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation 101 : 378-384, 2000.
 
16) Dargie HJ : Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction ; the CAPRICORN randomised trial. Lancet 357 : 1385-1390, 2001.
PubMed
17) Packer M, et al. ; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group : Effect of carvedilol on the morbidity of patients with severe chronic heart failure ; results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 : 2194-2199, 2002.
 
18) Poole-Wilson PA, et al. ; Carvedilol Or Metoprolol European Trial Investigators : Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET) ; randomised controlled trial. Lancet 362 : 7-13, 2003.
 
19) Hori M, et al. ; MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure : the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 147 : 324-330, 2004
PubMed
20) Willenheimer R, et al. ; CIBIS III Investigators : Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence ; results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112 : 2426-2435, 2005.
PubMed
21) Pitt B, et al. ; the Randomized Aldactone Evaluation Study Investigators : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 : 709-717, 1999.
 
22) Pitt B, et al. ; the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators : Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 : 1309-1321, 2003.
 
23) Zannad F, et al. : Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364 : 11-21, 2011.
PubMed
24) Cohn JN, Tognoni G ; the Valsartan Heart Failure Trial Investigators : A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 : 1667-1675, 2001.
 
25) McMurray JJV, et al. : Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors ; the CHARM-Added trial. Lancet 362 : 767-771, 2003.
PubMed
26) Granger CB, et al. : Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors ; the CHARM-Alternative trial. Lancet 362 : 772-776, 2003.
PubMed
27) Matsumori A ; on behalf of the ARCH-J study investigators : Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J Heart Fail 5 : 669-677, 2003.
 
28) Pfeffer MA, et al. : Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 : 1893-1906, 2003.
 
29) Konstam MA, et al. : Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study) ; a randomised, double-blind trial. Lancet 374 : 1840-1848, 2009.
PubMed
30) Uretsky BF, et al. : Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure ; results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 22 : 955-962, 1993.
 
31) The Digitalis Investigation Group : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 : 525-533, 1997.
 
32) Konstam MA, et al. : Effects of oral tolvaptan in patients hospitalized for worsening heart failure ; the EVEREST Outcome Trial. JAMA 297 : 1319-1331, 2007.
PubMed
33) Masuyama T, et al. : Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J 76 : 833-842, 2012.
PubMed
34) Cohn JN, et al. : Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314 : 1547-1552, 1986.
 
35) Swedberg K, et al. : Ivabradine and outcomes in chronic heart failure (SHIFT) ; a randomised placebo-controlled study. Lancet 376 : 875-885, 2010.
PubMed
36) Solomon S, et al. : The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction ; a phase 2 double-blind randomised controlled trial. www.thelancet.com Published on line August 26, 2012 http://dx.doi.org/10.1016/50140-6736(12)61227-6
 
37) Abraham WT, et al. ; the MIRACLE Study Group : Cardiac resynchronization in chronic heart failure. N Engl J Med 346 : 1845-1853, 2002.
 
38) Bristow MR, et al. ; the COMPANION Investigators : Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 : 2140-2150, 2004.
 
39) Cleland JGE, et al. ; the CARE-HF study investigators : The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 : 1539-1549, 2005.
 
40) Moss AJ, et al. : Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 : 1933-1940, 1996.
PubMed
41) The AVID Investigators : A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 : 1576-1583, 1997.
 
42) Buxton AE, et al. ; the MUSTT investigators : A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 : 1882-1890, 1999.
 
43) Moss AJ, et al. ; the MADIT-II investigators : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 : 877-883, 2002.
 
44) Bardy GH, et al. ; the SCD-Heft investigators : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 

付録 : Furter Readings

P.286 掲載の参考文献
(1) 日本循環器学会 : 循環器領域における睡眠呼吸障害の診断・治療に関するガイドライン www.-j-circ.or.jp/guidelines/pdf/JCS2010,momomura.h.pdf
 
(1) Mann DL (ed) : Heart Failure ; A Companion to Braunwald's Heart Disease, 2nd ed : Elsevier Saunders : 2011
 
(2) 日本疫学会編 : 疫学 基礎から学ぶために : 南江堂 : 1996
 
(3) Kiple KF (ed) : The Cambridge Historical Dictionary of Disease : Cambridge University Press : 2003
 
(4) Straus SE, et al. (ed) : Evidence-Based Medicine ; How to Practice and Teach it, 4th ed : Churchill Livingstone : 2011
 
(5) 小室一成 : 循環器疾患のサイエンス : 南山堂 : 2010
 
(6) Opie LH : Heart Physiology ; From Cell to Circulation : Lippincott Williams & Wilkins : 2003
 
(7) 友田春夫 : 心不全 循環生理からみた診断と治療 : 医学書院 : 2010
 
(8) 佐藤幸人 : 心不全の基礎知識 100 : 文光堂 : 2011
 
(9) 眞茅みゆきほか : 心不全ケア教本 : メディカル・サイエンス・インターナショナル : 2012
 
(10) 吉村道博 : 心不全の病態と薬の使い方 : 中外医学社 : 2011
 
(11) 冠動脈疾患 (下) -診断と治療の進歩. 日本臨牀 69 (増刊 9) : 日本臨牀社 : 2011
 
(12) Kahn CR, et al. : Joslin's Diabetes Mellitus, 14th ed : Lippincott Williams & Wilkins : 2004
 
(13) 日本糖尿病学会編 : 科学的根拠に基づく糖尿病診療ガイドライン : 南江堂 : 2010
 
(14) 伴良雄編 : よくわかる甲状腺疾患のすべて 第2版 : 永井書店 : 2009
 
(15) 伊藤公一監修 : 甲状腺疾患診療の手引き : 全日本病院出版会 : 2012
 
(16) 川名正敏ほか編 : カラー版 循環器病学 基礎と臨床 : 西村書店 : 2010
 
(17) 松田誠 : 脚気をなくした男 高木兼寛伝 : 講談社 : 1990
 
(18) Javaheri S (ed) : Sleep Medicine Clinics Vol.2 ; Sleep and Cardiovascular Disease No.4 : Elsevier Saunders : 2007
 
(19) Kormos RL : Mechanical Circulatory Support ; A Companion to Braunwald's Heart Disease : Elsevier Saunders : 2011
 

書評

最近チェックした商品履歴

Loading...